第一医药(600833) - 2014 Q3 - 季度财报

Financial Performance - Operating revenue for the first nine months reached CNY 1,063,759,068.03, a 7.35% increase from the same period last year[7] - Net profit attributable to shareholders increased by 6.66% to CNY 29,121,952.94 compared to the previous year[7] - Total operating revenue for Q3 2014 reached ¥341,787,825.34, an increase of 13.2% compared to ¥301,888,993.55 in Q3 2013[25] - Net profit for Q3 2014 was ¥9,734,609.15, representing a 16.2% increase from ¥8,377,627.01 in Q3 2013[25] - Operating revenue for the first nine months of 2014 reached ¥479,450,517.77, an increase of 2.0% compared to ¥465,513,429.87 in the same period last year[27] - Net profit for the first nine months of 2014 was ¥21,209,095.06, down 9.2% from ¥23,364,962.37 in the previous year[27] - Total comprehensive income for the first nine months of 2014 was ¥86,152,105.71, compared to ¥14,495,008.77 in the same period last year[27] Assets and Liabilities - Total assets increased by 10.54% to CNY 1,012,685,435.96 compared to the end of the previous year[7] - Total liabilities increased to ¥393,581,399.00 from ¥380,025,845.87, showing a rise of approximately 3.9%[19] - The company's equity attributable to shareholders rose to ¥612,096,721.07 from ¥529,129,476.08, representing an increase of about 15.7%[19] - The non-current assets totaled ¥470,511,274.73, up from ¥389,321,531.61, indicating a growth of approximately 20.9%[18] - Total liabilities increased to ¥250,023,621.32 in Q3 2014, up from ¥236,163,672.66 in Q3 2013, marking a rise of 5.0%[23] - The total assets of the company reached ¥872,892,794.32 in Q3 2014, up from ¥784,035,057.30 in Q3 2013, reflecting a growth of 11.3%[23] Shareholder Information - The number of shareholders reached 22,449 by the end of the reporting period[11] - The top shareholder, Shanghai Xinduda Commercial Group Co., Ltd., holds 23.39% of shares, totaling 52,185,126 shares[11] Cash Flow - Net cash flow from operating activities surged by 98.38% to CNY 45,559,035.15 year-on-year[7] - Cash flow from operating activities for the first nine months of 2014 was ¥45,559,035.15, significantly up from ¥22,965,475.49 in the previous year[29] - Operating cash inflow for the period reached ¥527,065,904.03, an increase of 10.7% compared to ¥476,101,134.76 in the same period last year[31] - The net increase in cash and cash equivalents for the period was ¥28,500,440.23, compared to ¥18,511,717.39 last year, representing a growth of 54.1%[31] - The ending balance of cash and cash equivalents reached ¥92,842,142.00, up 42.3% from ¥65,327,266.49 at the end of the same period last year[31] Income and Expenses - Financial expenses decreased by 360.08% to -CNY 2,855,848.49, attributed to increased interest income[12] - Sales expenses for the first nine months of 2014 increased to ¥30,724,464.55, up from ¥25,325,280.21 in the previous year, reflecting a rise of 21.5%[27] - The company incurred a total operating cost of ¥406,606,187.07 for the first nine months, an increase of 3.9% from ¥391,488,645.64 in the previous year[27] Other Comprehensive Income - The company reported a significant increase in other comprehensive income, rising to ¥201,747,046.42 from ¥136,747,437.02, an increase of approximately 47.5%[19] - Other comprehensive income for the first nine months of 2014 was ¥64,943,010.65, compared to a loss of ¥8,869,953.60 in the same period last year[27]